Navigation Links
Amgen And Astellas Announce Japan Alliance
Date:5/28/2013

THOUSAND OAKS, Calif. and TOKYO, May 29, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN), the world's largest independent biotechnology company, and Astellas Pharma Inc. (Tokyo Stock Exchange: 4503, "Astellas"), a leading Tokyo-based global pharmaceutical company, today announced the companies have entered into a strategic alliance to provide new medicines to help address serious unmet medical needs of Japanese patients.

The alliance leverages the complementary capabilities of both companies through an innovative business model that combines Amgen's pipeline candidates with Astellas' deep knowledge of Japanese patient and physician needs, long-term commercial and regulatory experience, and strong presence as a leading company in Japan.

The first element of the alliance is a long-term collaboration between the two companies that will focus on the co-development and co-commercialization in Japan of five Amgen pipeline medicines. The five medicines, which include four biologics and one small molecule, are focused on the treatment of cardiovascular and bone diseases and cancer. The pipeline medicines range from early to late stages of development in Japan, with the first potential commercial launch expected as early as 2016.

The second element of the alliance is the establishment of a Tokyo-based joint venture company through which the companies will work together to enable Amgen to rapidly build on-the-ground capabilities in Japan. The joint venture will operate under the name Amgen Astellas BioPharma KK and will be led by Eiichi Takahashi , who will serve as general manager. Additional management roles will be appointed by Am
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015 About artificial organs ... are implanted or integrated into individuals to ... artificial heart, kidney, pancreas, and cochlear implants. ... and porous polypropylene), biologics, ceramics, and metals ... organs are incorporated with different technologies like ...
(Date:9/3/2015)...  WellCare Health Plans, Inc. (NYSE: WCG ) ... president and chief financial officer, is scheduled to present ... Wednesday, September 9, 2015, at 9:25 a.m. Eastern time. ... addition, a replay of the webcast will be available ... live broadcast and the replay will be available on ...
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... ) has announced the addition of the ... report to their offering. The clinical ... to its wide application and good efficacy especially ... slowing down ageing in recent years. Progesterone, ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2China Progesterone Market Investigation Report 2015-2019 2
... Oral Presentation by Dr. Robert Figlin Highlights Phase 2 Data Showing ... Perifosine, Used as a Single Agent and Phase 1 Data ... Toxicity ... Biopharmaceuticals,Inc. today announced positive phase 1 & 2 data of perifosine ...
... MRSA School Scare Every day brings new reports ... -- of MRSA (methicillin-resistant staphylococcus aureus),a potentially lethal form ... and colleges. The most prominent symptoms,include skin abscesses and/or ... care facilities and attacks,those with low immune systems, children ...
Cached Medicine Technology:Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 2Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 3Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 4Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 5Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 6Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 7An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R) 2An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R) 3
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® ... medical devices, announced its only mission and research focus: Water Life Science®. In ... Kleyne, body water evaporation is becoming dangerously accelerated. As a result of the ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute is proud to announce ... Doximity. Faculty, residents and staff are honored to have contributed to the success ... our ophthalmology residency program. Our faculty places a high priority on our educational programs ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program ... Hollywood, Florida October 9-10, 2015 at the Diplomat Resort & Spa has been ... doctors and researchers at the top of their field and will be presenting ...
(Date:9/4/2015)... ... 04, 2015 , ... Having access to a doctor can sometimes be a ... of unnecessary emergency room visits which affects hospitals’ abilities to provide quality service to ... a solution to alleviate this problem has recently presented itself, the new telemedicine platform ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... its first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. ... area and feature 30 cottage or “pocket” homes. In this community, adults will ...
Breaking Medicine News(10 mins):Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... invasive interventional radiology treatment for women that cuts off ... highlighted as an appropriate treatment for women in a ... the New England Journal of Medicine . ... a safe, effective and minimally invasive option for women ...
... , , , ... SIAL ) today announced an agreement with Glycosan BioSystems ... matrix (ECM) for stem cell research. HyStem offers researchers flexibility ... in vivo conditions, optimizing stem cell proliferation and ...
... , , , ... Sheets: JEDM) ( http://www.jedimindinc.com ) announced today that a " 60 ... more credibility to "mind control" software and hardware applications. During the ... which is basically an EEG cap that reads signals from the ...
... , DENVER, Aug. 13 Birner Dental Management ... of PERFECT TEETH dental practices , ... 2009. For the quarter ended June 30, 2009, total dental group ... increased $93,000, or 1.1%, to $8.9 million. The Company,s earnings before ...
... disorders, method cuts death risk, study finds , WEDNESDAY, ... disorders who receive early non-invasive ventilation after a breathing ... respiratory failure or die, a Spanish study has found. ... All of them had high levels of carbon dioxide ...
... does increase likelihood of extensive surgery, researchers say , THURSDAY, ... surgery to assess the extent of early breast cancer may ... The study authors said this use of MRI increases the ... a conservative therapy, but that this more aggressive treatment doesn,t ...
Cached Medicine News:Health News:Interventional radiology treatment for uterine fibroids: Safe, nonsurgical option 2Health News:Interventional radiology treatment for uterine fibroids: Safe, nonsurgical option 3Health News:Sigma-Aldrich Offers Customizable Synthetic Extracellular Matrix for Stem Cell Research 2Health News:Sigma-Aldrich Offers Customizable Synthetic Extracellular Matrix for Stem Cell Research 3Health News:Mind Control Goes Mainstream on CBS's '60 Minutes' 2Health News:Birner Dental Management Services, Inc. Announces Earnings Per Share Up 33% for 2nd Quarter 2009 2Health News:Birner Dental Management Services, Inc. Announces Earnings Per Share Up 33% for 2nd Quarter 2009 3Health News:Birner Dental Management Services, Inc. Announces Earnings Per Share Up 33% for 2nd Quarter 2009 4Health News:Birner Dental Management Services, Inc. Announces Earnings Per Share Up 33% for 2nd Quarter 2009 5Health News:Birner Dental Management Services, Inc. Announces Earnings Per Share Up 33% for 2nd Quarter 2009 6Health News:Birner Dental Management Services, Inc. Announces Earnings Per Share Up 33% for 2nd Quarter 2009 7Health News:Birner Dental Management Services, Inc. Announces Earnings Per Share Up 33% for 2nd Quarter 2009 8Health News:Birner Dental Management Services, Inc. Announces Earnings Per Share Up 33% for 2nd Quarter 2009 9Health News:Birner Dental Management Services, Inc. Announces Earnings Per Share Up 33% for 2nd Quarter 2009 10Health News:Ventilation After Breathing Tube Removal May Alter Outcomes 2
...
The Tew cranial/spinal retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required. Clinical applications are: Posterior fossa microsurgery and intraspinal micr...
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required....
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm)....
Medicine Products: